Healthcare, Pharma & Life Sciences
USFDA inspections, generic drug manufacturing, hospital chains, health insurance and biotechnology.
Top 10 Stories in Healthcare, Pharma & Life Sciences
Continuous reported updates and desk briefings in Healthcare, Pharma & Life Sciences
⚡ Lead Investigation in Healthcare, Pharma & Life Sciences
"Health Ministry Proposes Drug Rules Amendment to Ease Regulation of Medicinal Gases, Empty Gelatin Capsules and Disinfectant Liquids"
India’s Health Ministry has proposed amendments to the Drugs Rules, 1945, aimed at introducing greater regulatory flexibility for medicinal gases, empty gelatin capsules and disinfectant liquids. The move signals a broader effort to streamline compliance while preserving quality and safety oversight across essential pharmaceutical inputs.

Full Healthcare, Pharma & Life Sciences Story Archive
Browse, filter, and explore all verified dispatches from national correspondents.
Tech Is Powering a Healthier Investment Era as Healthcare Enters a New Digital Age
Healthcare is moving into a new phase in which sensors, wearables, 3D-printed skin, reconstructed organs and data-driven clinical trials are no longer futuristic concepts but investable technologies. For markets and wealth creators, the shift is opening a broad opportunity set across medtech, biotech, diagnostics and digital health, while also raising the bar for regulation, validation and commercial scale.
India Launches Statewide Drive to Protect Children Against Tetanus and Diphtheria
India has begun a statewide vaccination drive aimed at strengthening protection for children aged 10 and 16 against tetanus and diphtheria, two potentially serious vaccine-preventable diseases. The initiative builds on early-life immunisation coverage, with officials emphasising that the TD vaccine provides an additional shield after children receive Pentavalent vaccines in infancy.

CCI Approves Rasmalai Limited’s Acquisition of Stake in Yatharth Hospital and Trauma Care Services
India’s competition regulator has cleared Rasmalai Limited’s proposed acquisition of certain shareholding in Yatharth Hospital and Trauma Care Services Limited, removing a key regulatory hurdle for the transaction. The approval signals that the deal does not raise competition concerns significant enough to warrant intervention under the current review framework.
Kerala High Court Says Police Fully Empowered to Tackle Drug Abuse in City
The Kerala High Court has clarified that police retain full authority to maintain vigilant oversight of drug and substance abuse-related activity in the city. The court said directions issued by a Single Bench would not prevent law enforcement from exercising the necessary watchfulness and action required to curb the menace.
Indira IVF in Talks to Buy Sabine Hospital in Nearly Rs 1,300 Crore Deal
Indira IVF is in discussions to acquire Sabine Hospital and Research Centre in a transaction valued at about ₹1,200-1,300 crore, according to people familiar with the matter. The proposed deal would expand Indira IVF’s footprint in India’s fertility care market and deepen its presence in Kerala, where Sabine operates two facilities offering fertility and maternal healthcare services.
Indira IVF in Talks to Acquire Sabine in Nearly ₹1,300 Crore Deal
Indira IVF is in discussions to acquire Sabine Hospital and Research Centre in a transaction valued at about ₹1,200-1,300 crore, according to people familiar with the matter. The proposed deal would deepen Indira IVF’s footprint in fertility and maternal healthcare, particularly in Kerala, where Sabine operates two facilities and is projected to generate ₹230-250 crore in revenue by FY27.

CBN Marks 77 Years With Push for Digital Enforcement and Youth Protection
India’s Central Bureau of Narcotics marked its 77th foundation day by reaffirming a tougher national approach to narcotics control, combining field enforcement with digital governance and youth-focused prevention. The agency framed its mandate around the broader national vision of a drug-free youth population and a developed India, underscoring the growing policy link between public health, security and administrative modernization.
Tech Is Rewiring Healthcare Into a Faster, Smarter Market
From biosensors and wearables to 3D-printed skin, reconstructed organs and AI-assisted clinical trials, healthcare is entering a technology-led phase that could reshape both patient outcomes and capital markets. The shift is drawing investor attention to companies positioned at the intersection of medtech, biotech and digital health, where scale, regulation and clinical validation will determine winners.

ESIC Medical College and Hospital in Faridabad Successfully Performs Corneal Transplant Surgery
ESIC Medical College and Hospital in Faridabad has successfully carried out a corneal transplant, marking a notable clinical milestone for the employee-state insurance healthcare network. The procedure underscores the growing capacity of public-sector medical institutions to deliver advanced eye care and expand access to sight-restoring surgery for insured and underserved patients.
Niloufer Superintendent Says Pregnant Women in Corridors Should Not Be Counted as Overcrowding
The superintendent of Niloufer Hospital has pushed back against claims of overcrowding, saying pregnant women waiting in corridors and common areas should not automatically be treated as evidence of excess patient load. The remarks come amid renewed scrutiny of public hospital capacity, crowd management, and the strain on maternity services in Telangana's public health system.
India Moves to Suspend Drug Manufacturing Licences Immediately Over Quality Failures
India is proposing a tougher regulatory regime that would allow authorities to suspend drug manufacturing licences immediately when quality failures are detected, a move aimed at preventing substandard medicines from remaining in circulation while manufacturers correct deficiencies. The proposal signals a sharper enforcement posture in one of the world’s largest pharmaceutical markets, where quality lapses can quickly become a public health and export credibility issue.
Indira IVF in Talks to Acquire Sabine in Nearly ₹1,300 Crore Deal
Indira IVF is in discussions to acquire Sabine Hospital and Research Centre in a transaction valued at about ₹1,200-1,300 crore, according to people familiar with the matter. The deal would deepen Indira IVF’s footprint in India’s fertility care market and add a Kerala-based platform with two facilities and a projected FY27 revenue of ₹230-250 crore.
